Do analysts recommend TACO or AMN?

AMN Healthcare Services has a consensus target price of $31.43, indicating a potential downside of 8.85%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 AMN Healthcare Services 2 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.22

Which has stronger earnings and valuation, TACO or AMN?

Berto Acquisition has higher earnings, but lower revenue than AMN Healthcare Services. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A AMN Healthcare Services $2.73B 0.49 -$95.70M $2.68 12.87

Does the media favor TACO or AMN?

In the previous week, AMN Healthcare Services had 1 more articles in the media than Berto Acquisition. MarketBeat recorded 4 mentions for AMN Healthcare Services and 3 mentions for Berto Acquisition. AMN Healthcare Services' average media sentiment score of 0.72 beat Berto Acquisition's score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AMN Healthcare Services 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer TACO or LMRI?

Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 28.82%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Lumexa Imaging 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has preferable valuation and earnings, TACO or LMRI?

Berto Acquisition has higher earnings, but lower revenue than Lumexa Imaging. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Lumexa Imaging $267.73M 4.46 -$47.10M -$0.49 N/A

Is TACO or LMRI more profitable?

Company Net Margins Return on Equity Return on Assets Berto Acquisition N/A N/A N/A Lumexa Imaging N/A N/A N/A

Do analysts prefer OPK or TACO?

OPKO Health currently has a consensus target price of $1.55, indicating a potential upside of 4.73%. Given OPKO Health's stronger consensus rating and higher possible upside, research analysts plainly believe OPKO Health is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OPKO Health 1 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, OPK or TACO?

Berto Acquisition has lower revenue, but higher earnings than OPKO Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio OPKO Health $606.90M 1.82 -$225.68M -$0.09 N/A Berto Acquisition N/A N/A N/A N/A N/A

Does the media prefer OPK or TACO?

In the previous week, OPKO Health had 7 more articles in the media than Berto Acquisition. MarketBeat recorded 10 mentions for OPKO Health and 3 mentions for Berto Acquisition. OPKO Health's average media sentiment score of 0.43 beat Berto Acquisition's score of 0.00 indicating that OPKO Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OPKO Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Berto Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer TACO or CSTL?

Castle Biosciences has a consensus price target of $42.00, indicating a potential upside of 22.81%. Given Castle Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Castle Biosciences is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Castle Biosciences 1 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.80

Which has higher earnings & valuation, TACO or CSTL?

Berto Acquisition has higher earnings, but lower revenue than Castle Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Castle Biosciences $344.23M 3.04 -$24.16M -$0.66 N/A

Does the media prefer TACO or CSTL?

In the previous week, Castle Biosciences had 2 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for Castle Biosciences and 3 mentions for Berto Acquisition. Castle Biosciences' average media sentiment score of 0.91 beat Berto Acquisition's score of 0.00 indicating that Castle Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Castle Biosciences 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate TACO or TALK?

Talkspace has a consensus price target of $5.56, suggesting a potential upside of 5.95%. Given Talkspace's stronger consensus rating and higher probable upside, analysts clearly believe Talkspace is more favorable than Berto Acquisition. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Berto Acquisition 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Talkspace 1 Sell rating(s) 7 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings & valuation, TACO or TALK?

Talkspace has higher revenue and earnings than Berto Acquisition. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Berto Acquisition N/A N/A N/A N/A N/A Talkspace $228.87M 3.84 $7.79M N/A N/A

Does the media favor TACO or TALK?

In the previous week, Talkspace had 4 more articles in the media than Berto Acquisition. MarketBeat recorded 7 mentions for Talkspace and 3 mentions for Berto Acquisition. Talkspace's average media sentiment score of 0.24 beat Berto Acquisition's score of 0.00 indicating that Talkspace is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Berto Acquisition 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Talkspace 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Berto Acquisition (TACO) Competitors

$10.46 0.00 (0.00%)

As of 08/21/2026 04:00 PM Eastern

Compare

TACO vs. AMN, LMRI, OPK, CSTL, and TALK

Should you buy Berto Acquisition stock or one of its competitors? Berto Acquisition's main competitors and comparable companies include AMN Healthcare Services (AMN), Lumexa Imaging (LMRI), OPKO Health (OPK), Castle Biosciences (CSTL), and Talkspace (TALK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Berto Acquisition compare to AMN Healthcare Services?

Berto Acquisition (NASDAQ:TACO) and AMN Healthcare Services (NYSE:AMN) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

Berto Acquisition has a beta of 0.07, indicating that its stock price is 93% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

In the previous week, AMN Healthcare Services had 1 more articles in the media than Berto Acquisition. MarketBeat recorded 4 mentions for AMN Healthcare Services and 3 mentions for Berto Acquisition. AMN Healthcare Services' average media sentiment score of 0.72 beat Berto Acquisition's score of 0.00 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AMN Healthcare Services	4 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

99.2% of AMN Healthcare Services shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

AMN Healthcare Services has a consensus target price of $31.43, indicating a potential downside of 8.85%. Given AMN Healthcare Services' stronger consensus rating and higher probable upside, analysts plainly believe AMN Healthcare Services is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

Berto Acquisition has higher earnings, but lower revenue than AMN Healthcare Services.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
AMN Healthcare Services	$2.73B	0.49	-$95.70M	$2.68	12.87

AMN Healthcare Services has a net margin of 3.06% compared to Berto Acquisition's net margin of 0.00%. AMN Healthcare Services' return on equity of 19.92% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
AMN Healthcare Services	3.06%	19.92%	5.93%

Summary

AMN Healthcare Services beats Berto Acquisition on 12 of the 12 factors compared between the two stocks.

How does Berto Acquisition compare to Lumexa Imaging?

Berto Acquisition (NASDAQ:TACO) and Lumexa Imaging (NASDAQ:LMRI) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

In the previous week, Berto Acquisition had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 3 mentions for Berto Acquisition and 0 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 0.93 beat Berto Acquisition's score of 0.00 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Overall Sentiment
Berto Acquisition	Neutral
Lumexa Imaging	Positive

Berto Acquisition has higher earnings, but lower revenue than Lumexa Imaging.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Lumexa Imaging	$267.73M	4.46	-$47.10M	-$0.49	N/A

Lumexa Imaging has a consensus price target of $16.00, suggesting a potential upside of 28.82%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Lumexa Imaging	N/A	N/A	N/A

Summary

Lumexa Imaging beats Berto Acquisition on 6 of the 7 factors compared between the two stocks.

How does Berto Acquisition compare to OPKO Health?

OPKO Health (NASDAQ:OPK) and Berto Acquisition (NASDAQ:TACO) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

OPKO Health has a beta of 1.51, suggesting that its stock price is 51% more volatile than the broader market. Comparatively, Berto Acquisition has a beta of 0.07, suggesting that its stock price is 93% less volatile than the broader market.

Berto Acquisition has a net margin of 0.00% compared to OPKO Health's net margin of -12.40%. Berto Acquisition's return on equity of 0.00% beat OPKO Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OPKO Health	-12.40%	-5.88%	-3.83%
Berto Acquisition	N/A	N/A	N/A

64.6% of OPKO Health shares are held by institutional investors. 44.7% of OPKO Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, OPKO Health had 7 more articles in the media than Berto Acquisition. MarketBeat recorded 10 mentions for OPKO Health and 3 mentions for Berto Acquisition. OPKO Health's average media sentiment score of 0.43 beat Berto Acquisition's score of 0.00 indicating that OPKO Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OPKO Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Berto Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

OPKO Health currently has a consensus target price of $1.55, indicating a potential upside of 4.73%. Given OPKO Health's stronger consensus rating and higher possible upside, research analysts plainly believe OPKO Health is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OPKO Health	1 Sell rating(s)	3 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Berto Acquisition has lower revenue, but higher earnings than OPKO Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OPKO Health	$606.90M	1.82	-$225.68M	-$0.09	N/A
Berto Acquisition	N/A	N/A	N/A	N/A	N/A

Summary

OPKO Health beats Berto Acquisition on 9 of the 12 factors compared between the two stocks.

How does Berto Acquisition compare to Castle Biosciences?

Berto Acquisition (NASDAQ:TACO) and Castle Biosciences (NASDAQ:CSTL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, media sentiment, risk, analyst recommendations, dividends, valuation and profitability.

Berto Acquisition has a net margin of 0.00% compared to Castle Biosciences' net margin of -5.43%. Berto Acquisition's return on equity of 0.00% beat Castle Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Castle Biosciences	-5.43%	-4.15%	-3.45%

Castle Biosciences has a consensus price target of $42.00, indicating a potential upside of 22.81%. Given Castle Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Castle Biosciences is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Castle Biosciences	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.80

Berto Acquisition has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. Comparatively, Castle Biosciences has a beta of 0.98, suggesting that its share price is 2% less volatile than the broader market.

In the previous week, Castle Biosciences had 2 more articles in the media than Berto Acquisition. MarketBeat recorded 5 mentions for Castle Biosciences and 3 mentions for Berto Acquisition. Castle Biosciences' average media sentiment score of 0.91 beat Berto Acquisition's score of 0.00 indicating that Castle Biosciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Castle Biosciences	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

92.6% of Castle Biosciences shares are held by institutional investors. 6.1% of Castle Biosciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Berto Acquisition has higher earnings, but lower revenue than Castle Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Castle Biosciences	$344.23M	3.04	-$24.16M	-$0.66	N/A

Summary

Castle Biosciences beats Berto Acquisition on 10 of the 13 factors compared between the two stocks.

How does Berto Acquisition compare to Talkspace?

Berto Acquisition (NASDAQ:TACO) and Talkspace (NASDAQ:TALK) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

57.4% of Talkspace shares are owned by institutional investors. 23.5% of Talkspace shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Talkspace has a net margin of 0.08% compared to Berto Acquisition's net margin of 0.00%. Talkspace's return on equity of 0.17% beat Berto Acquisition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Berto Acquisition	N/A	N/A	N/A
Talkspace	0.08%	0.17%	0.14%

In the previous week, Talkspace had 4 more articles in the media than Berto Acquisition. MarketBeat recorded 7 mentions for Talkspace and 3 mentions for Berto Acquisition. Talkspace's average media sentiment score of 0.24 beat Berto Acquisition's score of 0.00 indicating that Talkspace is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Berto Acquisition	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Talkspace	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Berto Acquisition has a beta of 0.07, suggesting that its share price is 93% less volatile than the broader market. Comparatively, Talkspace has a beta of 1.1, suggesting that its share price is 10% more volatile than the broader market.

Talkspace has higher revenue and earnings than Berto Acquisition.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Berto Acquisition	N/A	N/A	N/A	N/A	N/A
Talkspace	$228.87M	3.84	$7.79M	N/A	N/A

Talkspace has a consensus price target of $5.56, suggesting a potential upside of 5.95%. Given Talkspace's stronger consensus rating and higher probable upside, analysts clearly believe Talkspace is more favorable than Berto Acquisition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Berto Acquisition	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Talkspace	1 Sell rating(s)	7 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

Talkspace beats Berto Acquisition on 12 of the 12 factors compared between the two stocks.

Get Berto Acquisition News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TACO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TACO vs. The Competition

Export

Metric	Berto Acquisition	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$341.21M	$9.84B	$7.32B	$12.82B
Dividend Yield	N/A	2.55%	2.54%	10.78%
P/E Ratio	N/A	34.38	272.90	24.25
Price / Sales	N/A	4.95	632.64	97.63
Price / Cash	N/A	24.64	29.03	36.90
Price / Book	N/A	5.40	11.25	6.42
Net Income	N/A	$309.96M	$3.47B	$348.89M
7 Day Performance	0.10%	0.99%	2.33%	0.57%
1 Month Performance	-0.19%	2.30%	7.72%	4.90%
1 Year Performance	1.41%	15.69%	25.22%	17.06%

Berto Acquisition Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TACO Berto Acquisition	N/A	$10.46 flat	N/A	+1.4%	$341.21M	N/A	N/A	7,892	Analyst Downgrade
AMN AMN Healthcare Services	1.7544 of 5 stars	$35.25 +2.1%	$31.43 -10.8%	+66.7%	$1.34B	$2.73B	13.15	2,664
LMRI Lumexa Imaging	2.823 of 5 stars	$11.85 -1.2%	$16.00 +35.0%	N/A	$1.15B	$267.73M	N/A	5,019	Gap Down
OPK OPKO Health	1.3569 of 5 stars	$1.46 +7.4%	$1.55 +6.2%	+5.0%	$1.02B	$606.90M	N/A	1,373
CSTL Castle Biosciences	3.5323 of 5 stars	$32.32 +11.3%	$42.00 +30.0%	+64.1%	$886.85M	$344.23M	N/A	540

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TACO) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Berto Acquisition (TACO) Competitors

TACO vs. AMN, LMRI, OPK, CSTL, and TALK

How does Berto Acquisition compare to AMN Healthcare Services?

Summary

How does Berto Acquisition compare to Lumexa Imaging?

Summary

How does Berto Acquisition compare to OPKO Health?

Summary

How does Berto Acquisition compare to Castle Biosciences?

Summary

How does Berto Acquisition compare to Talkspace?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACO vs. The Competition

Berto Acquisition Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Berto Acquisition (TACO) Competitors

TACO vs. AMN, LMRI, OPK, CSTL, and TALK

How does Berto Acquisition compare to AMN Healthcare Services?

Which has more risk & volatility, TACO or AMN?

Does the media favor TACO or AMN?

Do insiders and institutionals believe in TACO or AMN?

Do analysts recommend TACO or AMN?

Which has stronger earnings and valuation, TACO or AMN?

Is TACO or AMN more profitable?

Summary

How does Berto Acquisition compare to Lumexa Imaging?

Does the media favor TACO or LMRI?

Which has preferable valuation and earnings, TACO or LMRI?

Do analysts prefer TACO or LMRI?

Is TACO or LMRI more profitable?

Summary

How does Berto Acquisition compare to OPKO Health?

Which has more volatility and risk, OPK or TACO?

Is OPK or TACO more profitable?

Do insiders and institutionals believe in OPK or TACO?

Does the media prefer OPK or TACO?

Do analysts prefer OPK or TACO?

Which has better valuation and earnings, OPK or TACO?

Summary

How does Berto Acquisition compare to Castle Biosciences?

Is TACO or CSTL more profitable?

Do analysts prefer TACO or CSTL?

Which has more volatility & risk, TACO or CSTL?

Does the media prefer TACO or CSTL?

Do insiders & institutionals believe in TACO or CSTL?

Which has higher earnings & valuation, TACO or CSTL?

Summary

How does Berto Acquisition compare to Talkspace?

Do insiders and institutionals hold more shares of TACO or TALK?

Is TACO or TALK more profitable?

Does the media favor TACO or TALK?

Which has more volatility and risk, TACO or TALK?

Which has preferable earnings & valuation, TACO or TALK?

Do analysts rate TACO or TALK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TACO vs. The Competition

Berto Acquisition Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools